Ginkgo biloba and acetazolamide for acute mountain sickness: bias in participants may underestimate effectiveness of agents.

Heather L Elphick, David A Elphick

Journal: BMJ (Clinical research ed.) 2004;329(7458):172; author reply 172

PMID: 15258084

Free Full Text on PubMed Central View on PubMed

Abstract

DOI: 10.1136/bmj.329.7458.172

Link outs

Free resources

Full Text Sources:

https://pmc.ncbi.nlm.nih.gov/articles/pmid/1525808...
https://europepmc.org/abstract/MED/15258084

Medical:

https://medlineplus.gov/herbalmedicine.html

Subscription / membership required

Full Text Sources:

https://www.bmj.com/lookup/pmidlookup?view=long&pm...
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Acetazolamide, Altitude Sickness, Ginkgo biloba, Humans, Phytotherapy, Randomized Controlled Trials as Topic, Selection Bias

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.